PT  - JOURNAL ARTICLE
AU  - Fokas, Athanasios S.
AU  - Dikaios, Nikolaos
AU  - Kastis, George A.
TI  - COVID-19: Predictive Mathematical Models for the Number of Deaths in South Korea, Italy, Spain, France, UK, Germany, and USA
AID  - 10.1101/2020.05.08.20095489
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.05.08.20095489
4099  - http://medrxiv.org/content/early/2020/05/12/2020.05.08.20095489.short
4100  - http://medrxiv.org/content/early/2020/05/12/2020.05.08.20095489.full
AB  - We have recently introduced two novel mathematical models for characterizing the dynamics of the cumulative number of individuals in a given country reported to be infected with COVID-19. Here we show that these models can also be used for determining the time-evolution of the associated number of deaths. In particular, using data up to around the time that the rate of deaths reaches a maximum, these models provide estimates for the time that a plateau will be reached signifying that the epidemic is approaching its end, as well as for the cumulative number of deaths at that time. The plateau is defined to occur when the rate of deaths is 5% of the maximum rate. Results are presented for South Korea, Italy, Spain, France, UK, Germany, and USA. The number of COVID-19 deaths in other counties can be analyzed similarly.Competing Interest StatementThe authors have declared no competing interest.Funding StatementA.S.F. acknowledges support from EPSRC, UK, in the form of a Senior Fellowship. N.D. acknowledges support from Royal Society in the form of a fellowship.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesWe obtained the time-series data for the Coronavirus Disease (COVID-19) from the official site of the European Centre for Disease Prevention and Control. https://www.ecdc.europa.eu/en/geographical-distribution-2019-ncov-cases